GENFIT S.A.

NASDAQ: GNFT
Share price (12/20/24): $3.80
Market cap (12/20/24): $189 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/23 FY 2023

ended 12/31/22 FY 2022

ended 12/31/21 FY 2021

ended 12/31/20 FY 2020

ended 12/31/19 FY 2019

Prospectuses and Registrations Filter

Registration of securities for employees

Shelf registration

Prospectus supplement with pricing info

Registration of additional securities

Registration of securities on exchange

Ownership Filter

Tang Capital Partners LP

Tang Capital Partners LP

Citadel Advisors LLC

Citadel Advisors LLC

News Filter

Announces Corporate Updates and Upcoming Participation at the Liver Meeting® 2024

Reports Third Quarter 2024 Financial Information

GENFIT: Ipsen’s Iqirvo® (Elafibranor) Receives EU Approval as a First-In- Class Treatment for Primary Biliary Cholangitis Following U.S. FDA Accelerated Approval

Half-Year Business and Financial Report at June 30, 2024

Reports First Half-Year 2024 Financial Results and Provides Corporate Update

Proxies

No filings in this category.

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness